Notably, the HDAC inhibitors restores the learning and memory deficits in AD mouse models, especially in the early stage AD mouse cortex, making it a promising drug for AD (Fischer et al., 2007; Vadnal et al., 2012). Here, HDAC9 is linked to Alzheimer disease.